After Sen. John McCain (R-Ariz.) cast his dramatic thumbs down vote on the last ditch Senate effort to repeal the Affordable Care Act, the pharmaceutical industry’s decision to stay out of the public debate over the effort looked pretty smart.
By the time McCain voted in the early morning hours of July 28, most of the repeal and replace bill...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?